Testing a new multi-electrode system for muscle activity measurement
Micro-EMG: A Novel Multi-electrode System for Intramuscular Imaging of Human Motor Units
This study is testing a new device that measures muscle activity in multiple places at once to see if it can help doctors diagnose muscle diseases better than current methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Newcastle University Academic / other |
| Locations | 1 site (Newcastle upon Tyne) |
| Trial ID | NCT05713474 on ClinicalTrials.gov |
What this trial studies
This exploratory study aims to evaluate a novel multi-electrode electromyography system called MicroEMG, which records muscle activity from multiple points simultaneously. The goal is to assess the usability and design of this system in diagnosing muscle diseases more effectively than conventional methods. By analyzing the recorded signals from different patient groups, researchers hope to bridge the gap between initial testing and future confirmative studies. This study is crucial for determining whether the MicroEMG system can be used in clinical settings after further validation.
Who should consider this trial
Good fit: Ideal candidates include individuals with suspected muscle or nerve disorders who meet the specific inclusion criteria.
Not a fit: Patients with cardiac pacemakers, certain neurological disorders, or clotting disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and comfortable diagnostic procedures for muscle diseases.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in enhancing EMG techniques, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * For each of the five groups, six participants will be recruited, adding up to a total of 30 participants. Exclusion Criteria: * cardiac pacemakers or defibrillator implants. * alternative neurological disorders likely to affect the results of an EMG examination. * lymphedema or dialysis fistula in the body region to be studied with EMG. * patients taking clotting inhibitor (such as warfarin or direct oral anticoagulants). * clotting disorder (such as haemophilia or low platelets). * participants unable to consent in English where a translator is not available.
Where this trial is running
Newcastle upon Tyne
- RVI - Newcastle upon Tyne Hospitals NHS Foundation Trust — Newcastle upon Tyne, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Roger Whittaker — Newcastle University
- Study coordinator: Katrin Bangel
- Email: Katrin.Bangel@nhs.net
- Phone: 01912083543
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.